Concepedia

Mark Lomaga

ML

8

Publications

1.7K

Citations

8

H-Index

1999

Active since

Affiliations

University of Toronto(Current)

Probity Medical Research

Eli Lilly (United States)

Dermatology Consulting Services

University of Pittsburgh

Mark Lomaga is an author at University of Toronto specializing in medicine, glioma, and patient-reported outcomes.

Top concepts

Publications per year

1999–2024

8

Publications

8

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

Mark Lomaga, Wen‐Chen Yeh, Ildiko Sarosi et al. · Genes & Development · 1999 · 1.3K citations · Full text

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

Kristian Reich, Andreas Pinter, J.‐P. Lacour et al. · British Journal of Dermatology · 2017 · 185 citations · Full text

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis

Mark Lebwohl, Leon Kircik, Angela Moore et al. · JAMA · 2022 · 104 citations · Full text

Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Deficiency Results in Exencephaly and Is Required for Apoptosis within the Developing CNS

Mark Lomaga, Jeffrey T. Henderson, Andrew Elia et al. · Journal of Neuroscience · 2000 · 87 citations · Full text

, , +21

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children

Eric L. Simpson, Lawrence F. Eichenfield, Javier Alonso‐Llamazares et al. · JAMA Dermatology · 2024 · 43 citations · Full text

Rows per page

1–5 of 8